• Follow
  • Follow
  • Menu Item

Log in

Start free trial
  • Reports
    • Diagnostic Testing & Emerging Technologies
    • Lab Compliance Advisor
    • Laboratory Industry Report
    • National Lab Reporter
  • Articles
    • Diagnostic Testing and Emerging Technologies
      • DTC-dtet
      • Earnings-dtet
      • Emerging Tests-dtet
      • FDA-dtet
      • G2 Insider-dtet
    • Lab Compliance Advisor
      • Accreditation-lca
      • Brief Your CEO-lca
      • CLIA-lca
      • CMS-lca
      • Coding-lca
      • Compliance Corner-lca
      • Compliance Guidance-lca
      • Compliance Officers-lca
      • Compliance Perspectives-lca
      • Compliance Plans-lca
      • Compliance-lca
      • DOJ-lca
      • Employment-lca
      • Enforcement-lca
      • False Claims-lca
      • FDA-lca
    • Laboratory Industry Report
      • Capital-lir
      • CMS-lir
      • Deals-lir
      • Dx Pipeline-lir
      • Earnings-lir
      • Enforcement-lir
      • FDA-lir
      • Fee Schedules-lir
      • Funding-lir
    • National Lab Reporter
      • Guidelines at a Glance-nir
      • Health care reform-nir
      • HIPAA-nir
      • Labs in Court-nir
      • Legislation-nir
      • News-nir
      • OIG-nir
      • Reimbursement-nir
      • Safety-nir
  • News
  • Industry Perspectives
  • Webinars
  • Store

Diagnostic Testing and Emerging Technologies

LAB COMPLIANCE ADVISOR

LABORATORY INDUSTRY REPORT

NATIONAL LAB REPORTER

OIG Roundup

OIG Roundup

by Glenn S. Demby | May 17, 2023 | National Lab Reporter, OIG-nir

In this OIG roundup, we cover the agency’s plans to modernize and improve the useability of its Compliance Program Guidance, which was first published in 1998.

This content is for Paid Members only.
Login Register
Turning Whistleblower Lemons into Compliance Lemonade

Turning Whistleblower Lemons into Compliance Lemonade

by Glenn S. Demby | Apr 27, 2023 | Compliance Perspectives-lca, Lab Compliance Advisor

A False Claims Act whistleblower lawsuit can do significant damage to your lab and its reputation, even if the case lacks truth and merit.

This content is for Paid Members only.
Login Register
OIG OKs Pharma Company’s Use of Financial Help for Patients

OIG OKs Pharma Company’s Use of Financial Help for Patients

by Glenn S. Demby | Mar 24, 2023 | Compliance Guidance-lca, Lab Compliance Advisor

Recent Advisory Opinion sheds light on offering patients financial assistance so they can receive the provider’s products and services.

This content is for Paid Members only.
Login Register
Protect Your Lab against HIPAA Right of Access Liability Risks

Protect Your Lab against HIPAA Right of Access Liability Risks

by Glenn S. Demby | Apr 29, 2022 | Articles, Compliance Perspectives-lca, Featured, Lab Compliance Advisor

Key points to educate your staff on when it comes to patient requests for test records and other protected health information.

This content is for Paid Members only.
Login Register
A Model Script to Help Avoid HIPAA Right of Access Violations

A Model Script to Help Avoid HIPAA Right of Access Violations

by Glenn S. Demby | Apr 29, 2022 | Articles, Lab Compliance Advisor, Tool

This script helps prepare frontline staff to answer questions that patients seeking access to their PHI are likely to ask.

This content is for Paid Members only.
Login Register
« Older Entries

Log In


Join Now | Lost Password?

  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
Copyright © 2023 G2Intelligence.com